Yahoo Finance23d
AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum
Restylane and Relfydess. These presentations combined reinforce the strength of Galderma’s growth journey, its status as the pure-play category leader in dermatology, and its innovative pipeline.
AMWC 2025: Galderma Pushes the Innovation Frontier With Updates From Its Unparalleled Portfolio Designed to Meet the Needs of the Aesthetic Community
Galderma (SWX:GALD) will showcase a strong presence at the 23rd Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco from March 27-29, 2025, with two symposia, four Masterclass sessions, 11 ...
Mirage News6d
Galderma Unveils 2025 Aesthetic Innovations at AMWC
Galderma will present new data from across its portfolio, including findings from the RELAX and EXPRESSION studies on Relfydess® (RelabotulinumtoxinA ...
Morningstar3mon
Galderma's Good Progress With Drug Pipeline Bolsters Positive Outlook
Galderma also holds the global number-two market position in fillers and skin boosters with the brand Restylane (behind Juvederm, part of AbbVie), offering the broadest portfolio of products.
Business Wire23d
AAD 2025: Galderma to Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leadership and Strong Momentum
ZUG, Switzerland--(BUSINESS WIRE)--Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from ...
Mena FN23d
AAD 2025: Galderma To Present Extensive Updates From Across Its Dermatology Portfolio, Demonstrating Its Category Leader...
(BUSINESS WIRE )--Galderma will present updates from across its broad dermatology portfolio at the 2025 American Academy of Dermatology (AAD) Annual Meeting, taking place from March 7-11, 2025 in ...